Elucidation of the percutaneous absorption of chromium compounds by functional proteomics

Chromium compounds are known to be associated with cytotoxicity and carcinogenicity when applied via a skin route. The aim of this study was to evaluate the skin permeability and toxicological profiles of four chromium species. Chromium permeation across the skin, as determined by an in vitro Franz cell, decreased in the order of sodium chromate>potassium chromate>potassium dichromate>chromium nitrate. The uptake of chromium species within the skin generally showed a contrary trend to the results of permeation, although differences among the various compounds were not large. Levels of in vivo skin deposition of the four compounds showed no statistically significant differences. Potassium chromate produced the greatest disruption of the skin structure as determined by HE staining, followed in order by sodium chromate, potassium dichromate, and chromium nitrate. This indicates that hexavalent chromium elicited greater toxicity to the skin compared to trivalent chromium. A similar result was observed for the viability of skin fibroblasts. To improve our understanding of the molecular mechanisms leading to functional changes in proteins, proteomic tools, including 2‐DE and MS techniques combined with sequence database correlations, were applied to identify target proteins altered by pathologic states. Eight protein spots, corresponding to cutaneous enzymes involved in energy metabolism and chaperon proteins, which were identified and discussed in this study, were associated with skin cytotoxicity, immunity, and carcinogenesis. In addition, functional proteomics of skin tissues may provide a promising tool for developing therapeutic strategies and can serve as the basis for further research.

[1]  D. Basketter,et al.  Proteomic analysis of the response of EpiDerm cultures to sodium lauryl sulphate. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[2]  S. Macneil,et al.  Chromium‐ and nickel‐induced cytotoxicity in normal and transformed human keratinocytes: an investigation of pharmacological approaches to the prevention of Cr(VI)‐induced cytotoxicity , 1996, The British journal of dermatology.

[3]  Chun-Ming Huang,et al.  Surfactant Sodium Lauryl Sulfate Enhances Skin Vaccination , 2006, Molecular & Cellular Proteomics.

[4]  Max Costa,et al.  Toxicity and Carcinogenicity of Chromium Compounds in Humans , 2006 .

[5]  M. Mann,et al.  Proteomics to study genes and genomes , 2000, Nature.

[6]  Christiaan H. Schrag,et al.  New insights into the pathological mechanisms of cerebrotendinous xanthomatosis in the Taiwanese using genomic and proteomic tools , 2006, Proteomics.

[7]  B. Akgül,et al.  HPV8 early genes modulate differentiation and cell cycle of primary human adult keratinocytes , 2007, Experimental dermatology.

[8]  Stephen Barnes,et al.  Prospective highlights of functional skin proteomics. , 2005, Mass spectrometry reviews.

[9]  Tai-Long Pan,et al.  Expression, by functional proteomics, of spontaneous tolerance in rat orthotopic liver transplantation , 2004, Immunology.

[10]  Chun-Ming Huang,et al.  Comparative proteomic profiling of murine skin. , 2003, The Journal of investigative dermatology.

[11]  Nicole Sage,et al.  Proteomic analysis of the response of human lung cells to uranium , 2005, Proteomics.

[12]  Jaewon Lee,et al.  Mitochondrial ATP synthase is a target for TNBS‐induced protein carbonylation in XS‐106 dendritic cells , 2008, Proteomics.

[13]  Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium(VI). , 2005, Chemical research in toxicology.

[14]  H. Maibach,et al.  Chemical and pharmacologic skin irritation in man , 1991, Contact dermatitis.

[15]  M. A. Armienta-Hernández,et al.  Environmental exposure to chromium compounds in the valley of León, México. , 1995, Environmental health perspectives.

[16]  H. Maibach,et al.  In vitro permeation of nickel salts through human stratum corneum. , 2001, Acta dermato-venereologica. Supplementum.

[17]  N. Cherry,et al.  Occupational dermatitis related to chromium and cobalt: experience of dermatologists (EPIDERM) and occupational physicians (OPRA) in the U.K. over an 11‐year period (1993–2004) , 2007, The British journal of dermatology.

[18]  C. Hung,et al.  Delivery of resveratrol, a red wine polyphenol, from solutions and hydrogels via the skin. , 2008, Biological & pharmaceutical bulletin.

[19]  Y. Ikarashi,et al.  Evaluation of skin sensitization potential of nickel, chromium, titanium and zirconium salts using guinea-pigs and mice. , 1996, Biomaterials.

[20]  M. R. Simon,et al.  Methods for in vitro percutaneous absorption studies. VII: Use of excised human skin. , 1986, Journal of pharmaceutical sciences.

[21]  R. Bronaugh,et al.  Methods for in vitro percutaneous absorption studies. I. Comparison with in vivo results. , 1982, Toxicology and applied pharmacology.

[22]  J. Hostýnek,et al.  Factors determining percutaneous metal absorption. , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[23]  S. Monstrey,et al.  In vitro permeation of chromium species through porcine and human skin as determined by capillary electrophoresis–inductively coupled plasma–sector field mass spectrometry , 2006, Analytical and bioanalytical chemistry.

[24]  S. Flora,et al.  Threshold mechanisms and site specificity in chromium(VI) carcinogenesis , 2000 .

[25]  M. Červinka,et al.  The role of intracellular zinc in chromium(VI)-induced oxidative stress, DNA damage and apoptosis. , 2006, Chemico-biological interactions.

[26]  Zheng-Guo Cui,et al.  Signal transduction of p53-independent apoptotic pathway induced by hexavalent chromium in U937 cells. , 2004, Toxicology and applied pharmacology.

[27]  M. Hansen,et al.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. , 1989, Journal of immunological methods.

[28]  Morten Østergaard,et al.  Human proteomic databases: a powerful resource for functional genomics in health and disease. , 2002, Progress in biophysics and molecular biology.

[29]  D. Bagchi,et al.  Cytotoxicity and oxidative mechanisms of different forms of chromium. , 2002, Toxicology.

[30]  J. P. Mestres,et al.  The "in vitro" percutaneous penetration of three antioxidant compounds. , 2007, International journal of pharmaceutics.

[31]  P. Gross,et al.  Chromium-protein interactions. , 1969, Acta dermato-venereologica.

[32]  S. MacNeil,et al.  The effects of nickel and chromium on human keratinocytes: differences in viability, cell associated metal and IL-1alpha release. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[33]  G. Maina,et al.  In vitro percutaneous absorption of metal compounds. , 2007, Toxicology letters.

[34]  T. Menné,et al.  Permeation of chromium salts through human skin in vitro , 1992, Contact dermatitis.

[35]  P. Coulombe,et al.  A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth , 2006, Nature.

[36]  M. Babu,et al.  Cytotoxicity studies of chromium(III) complexes on human dermal fibroblasts. , 2005, Free radical biology & medicine.

[37]  T. Yoshioka,et al.  Environmental Exposure Assessment of Chromium and Other Tannery Pollutants at Hazaribagh Area, Dhaka, Bangladesh, and Health Risk , 2000 .

[38]  D. Belsito,et al.  Dermatological Toxicity of Hexavalent Chromium , 2007, Critical reviews in toxicology.

[39]  M. Červinka,et al.  Hexavalent chromium disrupts the actin cytoskeleton and induces mitochondria-dependent apoptosis in human dermal fibroblasts. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.

[40]  J. Willey,et al.  Chromium speciation in rainwater: temporal variability and atmospheric deposition. , 2002, Environmental science & technology.